NASDAQ: BCDA - BioCardia, Inc.

六个月盈利: -16.33%
股息率: 0.00%
部门: Healthcare

促销时间表 BioCardia, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 BioCardia, Inc.

BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease.

更多详情
The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2008-03-14
ISIN US09060U5074
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.biocardia.com
Цена ао 0.42
每日价格变化: +6.03% (2.32)
每周价格变化: +24.87% (1.97)
每月价格变化: +4.68% (2.35)
3个月内价格变化: -16.33% (2.94)
六个月内的价格变化: -16.33% (2.94)
每年价格变化: +272.73% (0.66)
3年内价格变化: +22.39% (2.01)
5年内价格变化: -32.04% (3.62)
10年价格变化: 0% (2.46)
年初以来价格变化: +2.5% (2.4)
所有参数

低估

姓名 意义 年级
P/S 28.86 1
P/BV -8.59 0
P/E 0 0
EV/EBITDA -1.24 0
全部的: 3.38

效率

姓名 意义 年级
ROA, % -387.38 0
ROE, % 721.83 10
全部的: 3.33

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 1.43

责任

姓名 意义 年级
Debt/EBITDA -0.1171 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -32.82 0
盈利能力 Ebitda, % -17.43 0
盈利能力 EPS, % 211.59 10
全部的: 2.2
更多详情

机构 体积 分享, %
CM Management, LLC 700000 14.44
Vanguard Group Inc 650763 13.42
Geode Capital Management, LLC 159648 3.29
Renaissance Technologies, LLC 88300 1.82
Family Management Corporation 77500 1.6
Susquehanna International Group, LLP 65426 1.35
Blackrock Inc. 42767 0.88
Virtu Financial LLC 41348 0.85
Citadel Advisors Llc 33629 0.69
Brown Advisory Inc. 33085 0.68



导师 职称 支付 出生年份
Dr. Peter A. Altman Ph.D. CEO, President & Director 515.51k 1967 (58 年)
Mr. David McClung Chief Financial Officer 370.86k 1963 (62 年)
Mr. Edward M. Gillis Senior Vice President of Devices 263.1k 1962 (63 年)

地址: United States, Sunnyvale. CA, 320 Soquel Way - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.biocardia.com